文献速递乳腺乳腺X线

接受乳腺癌筛查女性良性乳腺疾病的乳腺X线特征与后续乳腺癌风险

Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
PubMed 文献 · Eur Radiol · 2021-06-22

基于西班牙1995–2015年筛查队列10,650例组织学确诊良性乳腺疾病(BBD)女性,随访至2017年12月(中位5.9年),评估BBD亚型与乳腺X线特征及后续乳腺癌风险。后续乳腺癌268例(2.5%);以肿块为参照,结构扭曲aHR 2.21(95%CI 1.16–4.22)、多发表现aHR 1.89(95%CI 1.34–2.66)、不对称aHR 1.66(95%CI 0.84–3.28)、钙化aHR 1.60(95%CI 1.21–2.12)。

要点

  • BBD亚型乳腺X线表现不同:伴异型增生性病变钙化更多(43.9%),非增殖性病变肿块更多(59.1%)。
  • 以肿块为参照,结构扭曲后续乳腺癌风险最高(aHR 2.21,95%CI 1.16–4.22)。
  • 多发表现、钙化后续乳腺癌风险亦升高(aHR 1.89、1.60),不对称aHR 1.66但95%CI跨1。

核心结论

  • BBD亚型具有不同的乳腺X线表现;与肿块相比,结构扭曲、多发表现、不对称和钙化者的后续乳腺癌风险更高。

研究设计与样本

  • 西班牙筛查队列分析,纳入1995–2015年筛查且组织学确诊BBD并有乳腺X线表现的10,650例女性,随访至2017年12月(中位5.9年),采用Cox比例风险模型估计aHR。

关键影像表现/征象

  • 钙化在伴异型增生性病变中占43.9%,高于无异性增生性病变的36.8%和非增殖性病变的22.2%(p值<0.05)。
  • 肿块在非增殖性病变中占59.1%,高于无异性增生性病变的35.1%和伴异型增生性病变的30.0%(p值<0.05)。
  • 多发表现和结构扭曲在增殖性病变中分别占16.1%和4.7%,高于非增殖性病变的12.8%和1.9%。

诊断标准与关键数值

  • 以肿块为参照,结构扭曲后续乳腺癌aHR 2.21(95%CI 1.16–4.22)。
  • 以肿块为参照,多发表现后续乳腺癌aHR 1.89(95%CI 1.34–2.66)。
  • 以肿块为参照,不对称后续乳腺癌aHR 1.66(95%CI 0.84–3.28)。
  • 以肿块为参照,钙化后续乳腺癌aHR 1.60(95%CI 1.21–2.12)。
  • 后续乳腺癌共268例(2.5%)。

临床应用与阅片要点

  • 筛查中BBD女性的乳腺X线表现有助于临床评估。
  • 钙化多见于伴异型增生性BBD(高风险),肿块多见于低风险BBD。
  • 结构扭曲者后续乳腺癌超额风险高于肿块者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the mammographic features in women with benign breast disease (BBD) and the risk of subsequent breast cancer according to their mammographic findings.

METHODS: We analyzed data from a Spanish cohort of women screened from 1995 to 2015 and followed up until December 2017 (median follow-up, 5.9 years). We included 10,650 women who had both histologically confirmed BBD and mammographic findings. We evaluated proliferative and nonproliferative BBD subtypes, and their mammographic features: architectural distortion, asymmetries, calcifications, masses, and multiple findings. The adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) for breast cancer were estimated using a Cox proportional hazards model. We plotted the adjusted cumulative incidence curves.

RESULTS: Calcifications were more frequent in proliferative disease with atypia (43.9%) than without atypia (36.8%) or nonproliferative disease (22.2%; p value < 0.05). Masses were more frequent in nonproliferative lesions (59.1%) than in proliferative lesions without atypia (35.1%) or with atypia (30.0%; p value < 0.05). Multiple findings and architectural distortion were more likely in proliferative disease (16.1% and 4.7%) than in nonproliferative disease (12.8% and 1.9%). Subsequent breast cancer occurred in 268 (2.5%) women. Compared with women who had masses, the highest risk of subsequent breast cancer was found in those with architectural distortions (aHR, 2.21; 95% CI, 1.16-4.22), followed by those with multiple findings (aHR, 1.89; 95% CI, 1.34-2.66), asymmetries (aHR, 1.66; 95% CI, 0.84-3.28), and calcifications (aHR, 1.60; 95% CI, 1.21-2.12).

CONCLUSION: BBD subtypes showed distinct mammographic findings. The risk of subsequent breast cancer was high in those who have shown architectural distortion, multiple findings, asymmetries, and calcifications than in women with masses.

KEY POINTS: • The presence of mammographic findings in women attending breast cancer screening helps clinicians to assess women with benign breast disease (BBD). • Calcifications were frequent in BBDs with atypia, which are the ones with a high breast cancer risk, while masses were common in low-risk BBDs. • The excess risk of subsequent breast cancer in women with BBD was higher in those who showed architectural distortion compared to those with masses.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Posso M, Alcántara R, Vázquez I, et al. Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening. Eur Radiol. 2021. PMID: 34156554. doi:10.1007/s00330-021-08118-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。